IGF1 and metabolic disease: In particular, normalisation of the obesity-related so-called “functional hyposomatotropism” by surgical weight loss is associated with the reduction in lipid availability, adipose tissue insulin resistance and low-grade inflammation, underlining an important role of adipose tissue also for the regulation of GH-IGF-1 axis in metabolic diseases.